Related Experiment Video
Updated: Jun 27, 2026
08:02
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
Lactoferrin and cancer disease prevention
Lígia Rodrigues1, José Teixeira, Fernando Schmitt
1IBB-Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, Campus de Gualtar, 4710-057 Braga, Portugal. lrmr@deb.uminho.pt
Critical Reviews in Food Science and Nutrition
|December 19, 2008
Summary
Lactoferrin (LF), an iron-binding glycoprotein, plays a role in defense and has therapeutic potential in cancer prevention and treatment. This review explores LF
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Lactoferrin (LF) is an iron-binding glycoprotein found in exocrine secretions.
- It is involved in non-specific defense against pathogens and regulates iron homeostasis.
- LF exhibits roles in inflammation, cellular growth, differentiation, and cancer prevention.
Purpose of the Study:
- To review recent advances in understanding the multifunctional roles of Lactoferrin (LF).
- To explore the potential therapeutic applications of LF in cancer prevention and treatment.
Main Methods:
- Literature review of recent scientific advances.
- Analysis of mechanisms underlying LF's multifunctional roles.
- Exploration of future therapeutic perspectives for LF.
Main Results:
- LF demonstrates significant potential as a chemopreventive agent against cancer.
- LF possesses diverse physiological roles including immune defense and anti-cancer properties.
- Understanding LF's mechanisms is key to its therapeutic application.
Conclusions:
- Lactoferrin (LF) holds promise for cancer disease prevention and treatment.
- Further research into LF's mechanisms can unlock its full therapeutic potential.
- LF is a versatile molecule with significant implications for human health.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...